ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
UpStream Bio Inc.
5.81
+0.0800
1.40%
成交量:
14.19萬
成交額:
82.11萬
市值:
3.18億
市盈率:
-2.02
高:
5.87
開:
5.75
低:
5.70
收:
5.73
52周最高:
33.68
52周最低:
5.65
股本:
5,477.10萬
流通股本:
4,668.08萬
量比:
0.36
換手率:
0.30%
股息:
- -
股息率:
- -
每股收益(TTM):
-2.8758
每股收益(LYR):
-2.6636
淨資產收益率:
-46.05%
總資產收益率:
-30.28%
市淨率:
1.17
市盈率(LYR):
-2.18
資料載入中...
總覽
公司
新聞資訊
公告
Upstream Bio在2026年ERS大會上口頭報告Verekitug治療重度哮喘的二期Valiant試驗結果
美股速递
·
09/08
Upstream Bio公布Verekitug針對重症哮喘與CRSwNP的關鍵性III期臨床開發計劃
美股速递
·
09/01
Upstream Bio在EAACI 2026大會上公布新應答者分析:Verekitug在二期VIBRANT試驗中為絕大多數CRSwNP患者帶來具臨床意義的改善
美股速递
·
06/14
美國研究綜述-Adobe、Caseys General Stores、Oracle
路透中文
·
06/12
上游生物將在EAACI 2026口頭報告環節展示Verekitug針對CRSwNP的二期Vibrant試驗額外療效數據
美股速递
·
06/08
Upstream Bio在ATS 2026國際會議上公布Verekitug二期Vibrant試驗新數據,顯示其改善CRSwNP合併哮喘患者的哮喘症狀控制
美股速递
·
05/18
Upstream Bio Inc與Leerink Partners達成普通股銷售協議 擬融資1.5億美元——SEC文件披露
美股速递
·
03/27
Upstream Bio公布Verekitug三期臨床試驗戰略及2025年第四季度與全年財務業績
美股速递
·
03/26
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/UPB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"UPB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UPB\",,,,,undefined,":{"symbol":"UPB","market":"US","secType":"STK","nameCN":"UpStream Bio Inc.","latestPrice":5.81,"timestamp":1789406051914,"preClose":5.73,"halted":0,"volume":141896,"delay":0,"changeRate":0.01396160558464209,"floatShares":46680775,"shares":54771041,"eps":-2.875781,"marketStatus":"交易中","change":0.08,"latestTime":"09-14 13:14:12 EDT","open":5.75,"high":5.87,"low":5.7,"amount":821142.21928,"amplitude":0.029668,"askPrice":5.83,"askSize":450,"bidPrice":5.81,"bidSize":212,"shortable":3,"etf":0,"ttmEps":-2.875781,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":5.73,"preHourTrading":{"tag":"盘前","latestPrice":5.74,"preClose":5.73,"latestTime":"09:29 EDT","volume":183,"amount":1048.643253,"timestamp":1789392599987,"change":0.01,"changeRate":0.001745,"amplitude":0.004677},"postHourTrading":{"tag":"盘后","latestPrice":5.73,"preClose":5.73,"latestTime":"19:30 EDT","volume":11114,"amount":63683.22,"timestamp":1789169407511,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.363249,"impliedVol":1.2467,"impliedVolPercentile":0.5578},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UPB\",,,,,undefined,":{"symbol":"UPB","floatShares":46680775,"roa":"-30.28%","roe":"-46.05%","lyrEps":-2.663615,"volumeRatio":0.363249,"shares":54771041,"dividePrice":0,"high":5.87,"amplitude":0.029668,"preClose":5.73,"low":5.7,"week52Low":5.65,"pbRate":"1.17","psRate":"100.77","week52High":33.68,"institutionHeld":0,"latestPrice":5.81,"committee":-0.359517,"eps":-2.875781,"divideRate":0,"volume":141896,"delay":0,"ttmEps":-2.875781,"open":5.75,"prevYearClose":27.15,"prevWeekClose":5.73,"prevMonthClose":6.62,"prevQuarterClose":6.92,"fiveDayClose":6.01,"twentyDayClose":7.07,"sixtyDayClose":6.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/UPB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"UPB","fiscalQuarterEnding":"2026/06","expectedEps":-0.78,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.73},{"market":"US","date":"2026-05-13","symbol":"UPB","fiscalQuarterEnding":"2026/03","expectedEps":-0.8,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2026-03-26","symbol":"UPB","fiscalQuarterEnding":"2025/12","expectedEps":-0.73,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"pre","actualEps":-0.79},{"market":"US","date":"2025-05-06","symbol":"UPB","fiscalQuarterEnding":"2025/03","expectedEps":-0.49,"name":null,"time":"盤前","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-0.51},{"market":"US","date":"2025-03-12","symbol":"UPB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"UPB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"UPB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.625,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1781323200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/UPB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"UPB","date":"2026-09-11","current":-2.020321,"percent":1,"low":-36.237602,"twenty":-12.746327,"median":-7.948604,"eighty":-3.458465,"high":-2.012355,"avg":-9.379689,"sd":7.009366,"marketCap":314933485},"quantilePoints":[{"date":"2024-10-11","current":-21.547111,"twenty":-21.096119,"median":-20.419631,"eighty":-19.743142,"marketCap":872808815},{"date":"2024-10-18","current":-29.91246,"twenty":-29.856691,"median":-29.151973,"eighty":-22.814588,"marketCap":1211664002},{"date":"2024-10-25","current":-33.154958,"twenty":-33.128498,"median":-29.931472,"eighty":-28.137991,"marketCap":1343007876},{"date":"2024-10-31","current":-32.943274,"twenty":-33.154958,"median":-32.429578,"eighty":-29.151973,"marketCap":1334433205},{"date":"2024-11-08","current":-35.748083,"twenty":-33.28726,"median":-32.943274,"eighty":-29.633615,"marketCap":1448047598},{"date":"2024-11-15","current":-26.036965,"twenty":-33.27403,"median":-32.40745,"eighty":-26.47861,"marketCap":1390295829},{"date":"2024-11-22","current":-17.866537,"twenty":-33.154958,"median":-29.91246,"eighty":-25.555171,"marketCap":954019497},{"date":"2024-11-29","current":-21.951751,"twenty":-33.154958,"median":-29.151973,"eighty":-21.870823,"marketCap":1172157663},{"date":"2024-12-06","current":-22.082237,"twenty":-33.144374,"median":-26.689395,"eighty":-21.903572,"marketCap":1179125222},{"date":"2024-12-13","current":-20.486294,"twenty":-33.088806,"median":-26.036965,"eighty":-21.589777,"marketCap":1093906626},{"date":"2024-12-20","current":-16.672089,"twenty":-32.969734,"median":-24.742143,"eighty":-20.201232,"marketCap":890239542},{"date":"2024-12-27","current":-19.517686,"twenty":-32.858694,"median":-23.382078,"eighty":-19.472518,"marketCap":1042185906},{"date":"2025-01-03","current":-16.36093,"twenty":-32.784605,"median":-22.553994,"eighty":-19.153329,"marketCap":873624596},{"date":"2025-01-10","current":-16.250519,"twenty":-32.617811,"median":-22.077219,"eighty":-18.486847,"marketCap":867728970},{"date":"2025-01-17","current":-10.92067,"twenty":-31.635576,"median":-21.951751,"eighty":-17.320504,"marketCap":583131018},{"date":"2025-01-24","current":-10.810259,"twenty":-29.950484,"median":-21.600443,"eighty":-16.501454,"marketCap":577235392},{"date":"2025-01-31","current":-11.041119,"twenty":-29.91246,"median":-20.852659,"eighty":-16.230444,"marketCap":589562611},{"date":"2025-02-07","current":-8.561886,"twenty":-29.633615,"median":-19.703378,"eighty":-11.472726,"marketCap":457179006},{"date":"2025-02-14","current":-7.3574,"twenty":-29.151973,"median":-19.472518,"eighty":-10.92067,"marketCap":392863085},{"date":"2025-02-21","current":-8.260764,"twenty":-28.137991,"median":-19.276941,"eighty":-10.810259,"marketCap":441100026},{"date":"2025-02-28","current":-7.839194,"twenty":-27.097043,"median":-19.030874,"eighty":-9.965112,"marketCap":418589453},{"date":"2025-03-07","current":-8.451474,"twenty":-26.562924,"median":-18.338294,"eighty":-8.834903,"marketCap":451283380},{"date":"2025-03-14","current":-7.737899,"twenty":-26.318012,"median":-17.866537,"eighty":-8.491624,"marketCap":485986508},{"date":"2025-03-21","current":-6.875286,"twenty":-26.085144,"median":-16.857781,"eighty":-8.411325,"marketCap":431809204},{"date":"2025-03-28","current":-5.816236,"twenty":-26.012875,"median":-16.36093,"eighty":-8.168077,"marketCap":365294494},{"date":"2025-04-04","current":-5.380659,"twenty":-25.645507,"median":-16.240482,"eighty":-7.936302,"marketCap":337937638},{"date":"2025-04-11","current":-5.466066,"twenty":-24.254326,"median":-13.751211,"eighty":-7.734483,"marketCap":343301728},{"date":"2025-04-17","current":-7.191293,"twenty":-23.886958,"median":-11.472726,"eighty":-7.5722,"marketCap":451656335},{"date":"2025-04-25","current":-7.652492,"twenty":-23.286723,"median":-11.041119,"eighty":-7.514132,"marketCap":480622419},{"date":"2025-05-02","current":-7.693506,"twenty":-22.857123,"median":-10.850408,"eighty":-7.502769,"marketCap":483198327},{"date":"2025-05-09","current":-6.005612,"twenty":-22.499792,"median":-10.810259,"eighty":-7.378434,"marketCap":475536334},{"date":"2025-05-16","current":-5.964849,"twenty":-22.162536,"median":-10.288315,"eighty":-7.189481,"marketCap":472308712},{"date":"2025-05-23","current":-6.324914,"twenty":-22.076215,"median":-9.921951,"eighty":-6.77963,"marketCap":500819374},{"date":"2025-05-30","current":-6.352089,"twenty":-22.02402,"median":-9.013568,"eighty":-6.524152,"marketCap":502971123},{"date":"2025-06-06","current":-7.357554,"twenty":-21.951751,"median":-8.668839,"eighty":-6.524152,"marketCap":582585803},{"date":"2025-06-13","current":-7.853492,"twenty":-21.855392,"median":-8.531773,"eighty":-6.551855,"marketCap":621855206},{"date":"2025-06-20","current":-7.228474,"twenty":-21.688772,"median":-8.441437,"eighty":-6.588317,"marketCap":572364999},{"date":"2025-06-27","current":-7.432284,"twenty":-21.589777,"median":-8.421362,"eighty":-6.683973,"marketCap":588503110},{"date":"2025-07-03","current":-7.60892,"twenty":-21.547111,"median":-8.293047,"eighty":-6.875286,"marketCap":602489473},{"date":"2025-07-11","current":-8.043715,"twenty":-21.219023,"median":-8.229183,"eighty":-7.004282,"marketCap":636917443},{"date":"2025-07-18","current":-7.500221,"twenty":-20.486294,"median":-8.00983,"eighty":-7.116503,"marketCap":593882481},{"date":"2025-07-25","current":-9.06956,"twenty":-20.325696,"median":-7.964314,"eighty":-7.165671,"marketCap":718145935},{"date":"2025-08-01","current":-10.401121,"twenty":-19.703378,"median":-8.043715,"eighty":-7.186764,"marketCap":823581592},{"date":"2025-08-08","current":-8.173881,"twenty":-19.517686,"median":-8.19076,"eighty":-7.191293,"marketCap":853925323},{"date":"2025-08-15","current":-9.608438,"twenty":-19.472518,"median":-8.256445,"eighty":-7.228474,"marketCap":1003793530},{"date":"2025-08-22","current":-9.154334,"twenty":-19.472518,"median":-8.332111,"eighty":-7.228474,"marketCap":956353234},{"date":"2025-08-29","current":-8.648626,"twenty":-19.29215,"median":-8.429698,"eighty":-7.242061,"marketCap":903521996},{"date":"2025-09-05","current":-10.155428,"twenty":-19.267816,"median":-8.442215,"eighty":-7.274671,"marketCap":1060937523},{"date":"2025-09-12","current":-9.247219,"twenty":-19.117195,"median":-8.531282,"eighty":-7.282823,"marketCap":966056931},{"date":"2025-09-19","current":-8.911801,"twenty":-19.040911,"median":-8.561886,"eighty":-7.298422,"marketCap":931015804},{"date":"2025-09-26","current":-8.416414,"twenty":-18.814066,"median":-8.561394,"eighty":-7.303028,"marketCap":879262754},{"date":"2025-10-03","current":-9.592957,"twenty":-18.486847,"median":-8.591998,"eighty":-7.324944,"marketCap":1002176247},{"date":"2025-10-10","current":-10.212191,"twenty":-18.290115,"median":-8.630565,"eighty":-7.351996,"marketCap":1066867560},{"date":"2025-10-17","current":-11.4971,"twenty":-18.113457,"median":-8.648626,"eighty":-7.357523,"marketCap":1201102033},{"date":"2025-10-24","current":-10.903668,"twenty":-17.908694,"median":-8.694854,"eighty":-7.362988,"marketCap":1139106192},{"date":"2025-10-31","current":-13.298037,"twenty":-17.320504,"median":-8.903157,"eighty":-7.366819,"marketCap":1389245933},{"date":"2025-11-07","current":-10.460565,"twenty":-17.071577,"median":-8.919541,"eighty":-7.375835,"marketCap":1278553063},{"date":"2025-11-14","current":-10.319087,"twenty":-16.746366,"median":-8.953083,"eighty":-7.3842,"marketCap":1261260713},{"date":"2025-11-21","current":-11.035322,"twenty":-16.535581,"median":-9.042102,"eighty":-7.390371,"marketCap":1348803231},{"date":"2025-11-28","current":-12.644639,"twenty":-16.41714,"median":-9.068084,"eighty":-7.395598,"marketCap":1545503702},{"date":"2025-12-05","current":-12.264416,"twenty":-16.306728,"median":-9.154334,"eighty":-7.402392,"marketCap":1499030514},{"date":"2025-12-12","current":-12.145044,"twenty":-16.258549,"median":-9.253501,"eighty":-7.413262,"marketCap":1484440094},{"date":"2025-12-19","current":-13.201711,"twenty":-16.238474,"median":-9.412348,"eighty":-7.419454,"marketCap":1613592327},{"date":"2025-12-26","current":-13.38298,"twenty":-16.206354,"median":-9.577476,"eighty":-7.422171,"marketCap":1635748149},{"date":"2026-01-02","current":-12.003565,"twenty":-15.686418,"median":-9.608438,"eighty":-7.426849,"marketCap":1467147745},{"date":"2026-01-09","current":-12.175992,"twenty":-13.691713,"median":-9.623919,"eighty":-7.437719,"marketCap":1488222796},{"date":"2026-01-16","current":-13.661516,"twenty":-14.223893,"median":-9.706483,"eighty":-7.459459,"marketCap":1669792461},{"date":"2026-01-23","current":-14.055003,"twenty":-14.055003,"median":-9.763246,"eighty":-7.459459,"marketCap":1717886807},{"date":"2026-01-30","current":-13.679201,"twenty":-14.055003,"median":-9.837934,"eighty":-7.487886,"marketCap":1671954005},{"date":"2026-02-06","current":-11.495127,"twenty":-13.997527,"median":-9.967119,"eighty":-7.498759,"marketCap":1405003366},{"date":"2026-02-13","current":-5.659139,"twenty":-13.966579,"median":-10.045793,"eighty":-7.487886,"marketCap":691693964},{"date":"2026-02-20","current":-3.775707,"twenty":-13.794285,"median":-9.921951,"eighty":-7.430925,"marketCap":461489567},{"date":"2026-02-27","current":-3.49275,"twenty":-13.743121,"median":-9.768407,"eighty":-7.40375,"marketCap":426904868},{"date":"2026-03-06","current":-3.391062,"twenty":-13.712802,"median":-9.724309,"eighty":-7.375835,"marketCap":414475992},{"date":"2026-03-13","current":-4.171405,"twenty":-13.705728,"median":-9.63424,"eighty":-7.351996,"marketCap":509854106},{"date":"2026-03-20","current":-3.704968,"twenty":-13.684506,"median":-9.611018,"eighty":-7.282823,"marketCap":452843392},{"date":"2026-03-27","current":-3.71417,"twenty":-13.665053,"median":-9.577476,"eighty":-7.221038,"marketCap":532771662},{"date":"2026-04-02","current":-3.532065,"twenty":-13.632336,"median":-9.412348,"eighty":-7.146004,"marketCap":506650069},{"date":"2026-04-10","current":-3.953182,"twenty":-13.517385,"median":-9.253501,"eighty":-6.612231,"marketCap":567056254},{"date":"2026-04-17","current":-3.831779,"twenty":-13.45372,"median":-9.154334,"eighty":-6.50272,"marketCap":549641858},{"date":"2026-04-24","current":-3.642087,"twenty":-13.411276,"median":-9.068084,"eighty":-6.341219,"marketCap":522431865},{"date":"2026-05-01","current":-3.482746,"twenty":-13.38298,"median":-9.030487,"eighty":-6.247466,"marketCap":499575471},{"date":"2026-05-08","current":-3.408766,"twenty":-13.356783,"median":-8.950503,"eighty":-6.042298,"marketCap":488963574},{"date":"2026-05-15","current":-3.051413,"twenty":-13.336336,"median":-8.911801,"eighty":-5.873814,"marketCap":478351676},{"date":"2026-05-22","current":-2.936855,"twenty":-13.312561,"median":-8.871357,"eighty":-5.82388,"marketCap":460393081},{"date":"2026-05-29","current":-2.888254,"twenty":-13.287802,"median":-8.694854,"eighty":-5.684399,"marketCap":452774283},{"date":"2026-06-05","current":-2.579294,"twenty":-13.258302,"median":-8.648626,"eighty":-5.496812,"marketCap":404340495},{"date":"2026-06-12","current":-2.214791,"twenty":-13.222933,"median":-8.630565,"eighty":-5.216676,"marketCap":347199510},{"date":"2026-06-18","current":-2.134948,"twenty":-13.191984,"median":-8.604831,"eighty":-4.257618,"marketCap":334682913},{"date":"2026-06-26","current":-2.207848,"twenty":-13.129203,"median":-8.561886,"eighty":-4.092265,"marketCap":346111110},{"date":"2026-07-02","current":-2.527222,"twenty":-13.033705,"median":-8.501661,"eighty":-3.922831,"marketCap":396177498},{"date":"2026-07-10","current":-2.71121,"twenty":-12.989493,"median":-8.446844,"eighty":-3.831779,"marketCap":425020090},{"date":"2026-07-17","current":-2.509865,"twenty":-12.97623,"median":-8.429698,"eighty":-3.775707,"marketCap":393456498},{"date":"2026-07-24","current":-2.221734,"twenty":-12.962966,"median":-8.408673,"eighty":-3.733139,"marketCap":348287910},{"date":"2026-07-31","current":-2.280749,"twenty":-12.929663,"median":-8.332111,"eighty":-3.686663,"marketCap":357539308},{"date":"2026-08-07","current":-2.384893,"twenty":-12.91308,"median":-8.260764,"eighty":-3.654227,"marketCap":373865303},{"date":"2026-08-14","current":-2.418325,"twenty":-12.836708,"median":-8.229183,"eighty":-3.58648,"marketCap":378467893},{"date":"2026-08-21","current":-2.397327,"twenty":-12.813742,"median":-8.043715,"eighty":-3.543056,"marketCap":375181630},{"date":"2026-08-28","current":-2.376328,"twenty":-12.809108,"median":-7.975124,"eighty":-3.522202,"marketCap":371895368},{"date":"2026-09-04","current":-2.127846,"twenty":-12.758706,"median":-7.949605,"eighty":-3.486539,"marketCap":333007929},{"date":"2026-09-11","current":-2.012355,"twenty":-12.746327,"median":-7.948604,"eighty":-3.458465,"marketCap":314933485}],"updateTime":1789406042428},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"UPB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1137576544","title":"Upstream Bio在2026年ERS大會上口頭報告Verekitug治療重度哮喘的二期Valiant試驗結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1137576544","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137576544?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 15:35","pubTimestamp":1788852934,"startTime":"0","endTime":"0","summary":"UpStream Bio Inc.在2026年欧洲呼吸学会(ERS)大会上,通过口头报告的形式,对外公布了其候选药物Verekitug在治疗重度哮喘方面的二期Valiant临床试验数据。这场重要的学术报告吸引了众多呼吸领域专家的目光。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174103724","title":"Upstream Bio公布Verekitug針對重症哮喘與CRSwNP的關鍵性III期臨床開發計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1174103724","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174103724?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:01","pubTimestamp":1788260477,"startTime":"0","endTime":"0","summary":"Upstream Bio今日宣布,其核心在研药物Verekitug在重症哮喘及慢性鼻窦炎伴鼻息肉两大适应症上,均已锁定关键性III期临床开发路径。这一战略布局标志着该公司在呼吸与炎症疾病领域的研发管线迈入全新阶段。具体而言,Verekitug作为一款备受瞩目的候选疗法,其设计初衷直指重度哮喘患者群体中尚未被满足的迫切医疗需求。与此同时,针对CRSwNP这一同样困扰大量患者的慢性炎症性疾病,Upstream Bio亦同步规划了严谨的注册性试验方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117178706","title":"Upstream Bio在EAACI 2026大會上公布新應答者分析:Verekitug在二期VIBRANT試驗中為絕大多數CRSwNP患者帶來具臨床意義的改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1117178706","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117178706?lang=zh_tw&edition=fundamental","pubTime":"2026-06-14 22:00","pubTimestamp":1781445620,"startTime":"0","endTime":"0","summary":"Upstream Bio公司于2026年欧洲过敏与临床免疫学会大会上,公布了其候选药物Verekitug在二期VIBRANT试验中的最新应答者分析数据。结果显示,在接受Verekitug治疗的患者中,绝大多数患有慢性鼻窦炎伴鼻息肉的参与者,其病情获得了具有临床意义的显著改善。这项深入分析进一步证实了Verekitug作为一款潜在疗法的积极信号。此次在EAACI这一权威国际会议上展示的数据,增强了Verekitug在治疗CRSwNP这一领域的前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642686892","title":"美國研究綜述-Adobe、Caseys General Stores、Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2642686892","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642686892?lang=zh_tw&edition=fundamental","pubTime":"2026-06-12 15:34","pubTimestamp":1781249678,"startTime":"0","endTime":"0","summary":"美国研究综述-Adobe、Caseys General Stores、Oracle路透6月12日 - 周五,华尔街证券分析师下调了多家在美国上市公司的评级和目标股价,其中包括Adobe、Caseys General Stores和甲骨文。重点摘要 * Adobe Inc ADBE.O:Baird将目标价从270美元下调至230美元* 凯西百货公司 CASY.O:摩根大通将目标价从719美元上调至975美元* Oracle Corp ORCL.N:汇丰将目标价从345美元下调至316美元以下是路透周五报道的针对美国公司的研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nL4S42K0GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210536198.USD","LU1548497426.USD","LU1674673428.USD","BK4566","LU0417517546.SGD","LU1803068979.SGD","IE00BMPRXR70.SGD","LU0006306889.USD","IE00BBT3K403.USD","GH","IE00BN8TJ469.HKD","LU0868494617.USD","LU0061474960.USD","BK4122","BK4166","LU2264538146.SGD","SG9999000418.SGD","LU0106261372.USD","LU0889565833.HKD","BK4504","LU0868494708.USD","IE000WAW04H5.SGD","LU1046421795.USD","LU1069347547.HKD","LU1934455277.USD","LU2054465674.USD","LU2357305700.SGD","ORCX","LU1366192091.USD","MGM","IE00BMPRXN33.USD","LU0106261612.USD","LU0949170772.SGD","LU0070302665.USD","LU1037948897.HKD","LU2023251221.USD","RH","UPB","LU2065171311.SGD","LU0433182093.SGD","IE00B3T34201.USD","LU0957791311.USD","LU0345770993.USD","SGXZ99366536.SGD","LU0965508806.USD","BK4567","IE0009356076.USD","IE00BQXX3F31.USD","LU0719512351.SGD","LU2210149790.SGD","LU1989764748.USD","LU1267930813.SGD","IE00BYQQ9H92.USD","LU2896262040.SGD","IE00BLSP4239.USD","CASY","LU0323591593.USD","LU1201861249.SGD","LU1571399168.USD","IE00B3S45H60.SGD","LU1778281490.HKD","LU1244550221.USD","LU2543165471.USD","SGXZ81514606.USD","LU0289960550.SGD","LU1935043023.USD","LU0069063385.USD","LU0965509010.AUD","BK4533","LU0234570918.USD","LU0320765489.SGD","IE00BQXX3D17.EUR","LU1935042215.USD","LU1267930730.SGD","LU2089283258.USD","LU2237957902.USD","LU1989764664.SGD","LU0476273544.USD","LU1935043536.SGD","LU0157215616.USD","LU2317271919.USD","LU2458330243.SGD","LU0985489474.SGD","LU0553294199.USD","LU1712237335.SGD","LU1674673691.USD","LU1720051108.HKD","LU1934455194.USD","LU2125154778.USD","LU0130102774.USD","LU0175139822.USD","BK4528","BK4588","IE000MB6IJN5.SGD","LU1261432733.SGD","LU1815333072.USD","CVNX","BK4585","LU0198837287.USD","LU1989772840.SGD","LU0320765646.SGD","ORCS","BFH","IE00B19Z3B42.SGD","LU0792757196.USD","BK4150","BK4196","LU0234572021.USD","LU0957808578.USD","LU0348723411.USD","LU0511384066.AUD","LU1235294995.USD","LU2065171402.SGD","LU2108987350.USD","LU0158827948.USD","LU2125154935.USD","NTRA","LU1244550577.SGD","LU1894683348.USD","ORCU","LU1720051017.SGD","BK4187","LU0289961442.SGD","LU2237438978.USD","ORCL","LU0109392836.USD","BK4534","LU0314104364.USD","IE0009354923.USD","SG9999001424.SGD","BK4097","LU0353189763.USD","KTOS","BK4603","LU0444971666.USD","BK4106","LU1037948541.HKD","LU0256863811.USD","LU0878866978.SGD","LU0980610538.SGD","ADBE","LU0081259029.USD","IE00B775SV38.USD","LU0738911758.USD","LU0133085943.USD","IE00B7SZLL34.SGD","KTUP","LU1934455863.HKD","LU2087625088.SGD","LU0472753341.HKD","LU2065170008.USD","LU1244550494.USD","LU0965509101.SGD","BK4113","LU0965509283.SGD","LU2095319765.USD","LU1366333091.USD","BK4581","LU0170899867.USD","LU0353189680.USD","BK4561","IE00B5949003.HKD","LU1691799644.USD","BK4527","LU1162221912.USD","LU0557290698.USD","LU0942090050.USD","LU0672654240.SGD","LU0648001328.SGD","CVNY","LU0082616367.USD","LU0053671581.USD","BK4592","LU0109391861.USD","LU1929549753.HKD","LU2065731478.USD","BK4214","LU2360106780.USD","LU0098860793.USD","LU1989772923.USD","LU0068578508.USD","LU1823568750.SGD","IE00B5TLWC47.USD","LU2360032135.SGD","IE000BZT7R73.USD","LU1935042991.SGD","LU0012050646.USD","LU1064131342.USD","LU2458330169.SGD","LU2860962120.EUR","BK4551","LU0889566641.SGD","IE00BQXX3C00.GBP","LU0345774391.USD","LU0861579265.USD","LU0545039389.USD","BK4532","LU0661504455.SGD","BK4503","LU0708995401.HKD","IE0004445239.USD","LU2746668974.SGD","LU0314106906.USD","LU1633808545.USD","LU1642822529.SGD","LU2324357040.USD","LU0289739343.SGD","IE0002270589.USD","LU1623119135.USD","TENX","BK4538","BK4543","LU2326559502.SGD","IE00BLSP4452.SGD","LU0054578231.USD","LU0345770308.USD","BK4139","SG9999003800.SGD","LU1894683264.USD","BK4554","BK4516","LU0963586101.USD","LU1084165304.USD","LU1506573853.SGD","BK4023","LU0057025933.USD","LU1852331112.SGD","IE00BD6J9T35.USD","LU2210150020.SGD","LU1435385759.SGD","LU2250418816.HKD","IE000F7OJYX1.SGD","LU0208291251.USD","LU1489326972.SGD","LU2237957811.SGD","LU1119994496.HKD","LU0342679015.USD","CVNA","IE000SO60NU8.SGD","ETSY","IE00B19Z9505.USD","IE00BMPRXQ63.HKD","IE0000B7K699.USD","LU2089284900.SGD","SG9999011175.SGD","LU1815336760.USD","BK4220","ADBG","LU0056508442.USD","LU1988902786.USD","BK4178","LU1003077747.HKD","BK4559","LU0345774631.USD","BK4535","LU2236285917.USD","LU1935042488.USD","LU1429558221.USD","IE00BFXG0V08.USD","LU0444973449.USD","LU2746668461.USD","BK4550","IE00B19Z3581.USD","LU0320765059.SGD","LU1035773651.USD","SGXZ51526630.SGD","PEP","LU2065169927.USD","BK4548","BK4177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123552714","title":"上游生物將在EAACI 2026口頭報告環節展示Verekitug針對CRSwNP的二期Vibrant試驗額外療效數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1123552714","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123552714?lang=zh_tw&edition=fundamental","pubTime":"2026-06-08 19:00","pubTimestamp":1780916426,"startTime":"0","endTime":"0","summary":"上游生物公司计划在即将举行的欧洲过敏与临床免疫学会2026年大会上,通过口头报告形式,进一步公布其候选药物Verekitug用于治疗慢性鼻窦炎伴鼻息肉病的二期Vibrant临床试验的额外疗效数据。此次展示旨在向科学界提供关于该疗法潜力的更深入见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104582898","title":"Upstream Bio在ATS 2026國際會議上公布Verekitug二期Vibrant試驗新數據,顯示其改善CRSwNP合併哮喘患者的哮喘症狀控制","url":"https://stock-news.laohu8.com/highlight/detail?id=1104582898","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104582898?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 23:30","pubTimestamp":1779118224,"startTime":"0","endTime":"0","summary":"Upstream Bio在2026年美国胸科学会国际会议上,公布了其候选药物Verekitug在二期Vibrant临床试验中的最新数据。数据显示,对于同时患有慢性鼻窦炎伴鼻息肉和哮喘的患者,Verekitug在改善哮喘症状控制方面展现出积极效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121420417","title":"Upstream Bio Inc與Leerink Partners達成普通股銷售協議 擬融資1.5億美元——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1121420417","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121420417?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 05:07","pubTimestamp":1774559260,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会的文件显示,生物技术公司Upstream Bio Inc已与Leerink Partners LLC签署销售协议,计划通过公开发行普通股筹集最高1.5亿美元资金。该协议标志着这家专注于炎症性疾病创新疗法研发的企业正式启动资本市场融资通道。此次普通股发售将根据市场条件及其他因素逐步推进,Leerink Partners作为独家销售代理负责承销事宜。作为生物科技领域的新锐力量,Upstream Bio Inc正在开发针对严重炎症性疾病的突破性疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162420003","title":"Upstream Bio公布Verekitug三期臨床試驗戰略及2025年第四季度與全年財務業績","url":"https://stock-news.laohu8.com/highlight/detail?id=1162420003","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162420003?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 19:03","pubTimestamp":1774523017,"startTime":"0","endTime":"0","summary":"生物制药公司Upstream Bio近日宣布了其核心候选药物Verekitug的三期临床开发战略,并同步披露了2025年第四季度及全年的财务报告。此次公布标志着Verekitug的研发进入关键阶段,公司对其未来市场前景充满信心。财务数据则反映了公司在研发投入与业务运营方面的最新状况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}